Evidence map›Paper›PMID 39502900›Full record

ArticleInterventional pain medicine2024

A single-center retrospective chart review of percutaneous PNS for treatment of chronic shoulder pain.

Genaro J Gutierrez, Pankaj Mehta, Trey Mouch, Shawn Puri, Jacob R Caylor, William J Huffman, Nathan D Crosby, Joseph W Boggs

Abstract read
In one paragraph

Article in Interventional pain medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Genaro J GutierrezPain Specialists of America, 4100 Duval Road , Building 3, Suite 200, Austin, TX, 78759, USA.
Pankaj MehtaPain Specialists of America, 4100 Duval Road , Building 3, Suite 200, Austin, TX, 78759, USA.
Trey MouchPain Specialists of America, 4100 Duval Road , Building 3, Suite 200, Austin, TX, 78759, USA.
Shawn PuriPain Specialists of America, 4100 Duval Road , Building 3, Suite 200, Austin, TX, 78759, USA.
Jacob R CaylorPain Specialists of America, 4100 Duval Road , Building 3, Suite 200, Austin, TX, 78759, USA.
William J HuffmanSPR Therapeutics, 22901 Millcreek Blvd, Suite 500, Cleveland, OH, 44122, USA.
Nathan D CrosbySPR Therapeutics, 22901 Millcreek Blvd, Suite 500, Cleveland, OH, 44122, USA.
Joseph W BoggsSPR Therapeutics, 22901 Millcreek Blvd, Suite 500, Cleveland, OH, 44122, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The present IRB-approved retrospective chart review describes the use of a 60-day PNS treatment for shoulder pain at a single center in 60 total consecutive patients. Background: Chronic shoulder pain affects an increasing number of patients per year and is especially prevalent in elderly populations. Percutaneous peripheral nerve stimulation (PNS) treatment targeting the nerves of the shoulder has been shown to reduce pain in prospective clinical studies and in analysis of real-world data. Methods: Data were extracted from the electronic medical records of patients who had previously undergone percutaneous PNS treatment for chronic shoulder pain. Demographic data and treatment characteristics were summarized alongside treatment outcomes. Results: Overall, 84 % (49/58) of patients reported substantial (≥50 %) pain relief at the end-of-treatment. The records for 2 patients did not include patient-reported percent pain relief. The average indwelling period for leads (i.e., treatment period) was 57 days. Findings on treatment effectiveness were consistent when the patient population was stratified by cause of pain, duration living with pain, and presence of pain-modifying comorbidities. Stimulation paradigms were identified and categorized by the nerve target and stimulation frequency (e.g., motor stimulation, sensory stimulation, or bimodal stimulation). Conclusions: These results indicate percutaneous PNS is an effective treatment for patients with various shoulder pain histories, and while all stimulation paradigms were effective at reducing pain, patients who received bimodal PNS reported the greatest pain relief. Key limitations of the study included heterogeneous shoulder pain etiologies among patients and sparse availability of long-term follow-up data. These data support existing real-world and prospective clinical evidence on the efficacy of 60-day PNS treatment at treating chronic pain and provide valuable insights into its use in clinical practice.

Identifiers

PMID39502900
PMCPMC11536284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.